The investigational therapy uses SteadyTeq, a proprietary copolymer technology from Medincell designed to release olanzapine steadily over time
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
The study met its primary endpoint and all 11 secondary efficacy endpoints
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
Jacobio stated that these findings underscore the potential of glecirasib and sitneprotafib
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
The company also revealed that MK-2214 has received Fast Track Designation from the U.S. Food and Drug Administration
Here's a new ray of hope for new hope for patients suffering from Meniere’s disease (MD) and sensorineural hearing loss
Subscribe To Our Newsletter & Stay Updated
